Multimode participation of traditional Chinese medicine in the treatment of COVID-19

Background: The outbreak of COVID-19 has swiftly spread across China and all over the world, resulting in severe contagious pneumonia. However, no specific anti-COVID-19 drugs or methods are available for the treatment of this acute and fatal disease. In recent years, as the efficacy and safety of t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tieying Dai, Leyin Zhang, Xinyang Dai, Xinran Zhang, Beibei Lu, Yuxi Zheng, Deyi Shen, Yici Yan, Congqi Ji, Jieru Yu, Leitao Sun
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Traditional Chinese medicine (TCM) COVID-19 Multimode participation Treatment Miscellaneous systems and treatments RZ409.7-999
Acceso en línea:	https://doaj.org/article/b78c2d592a614450873b1aef20257936
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b78c2d592a614450873b1aef20257936
record_format	dspace
spelling	oai:doaj.org-article:b78c2d592a614450873b1aef202579362021-12-04T04:34:09ZMultimode participation of traditional Chinese medicine in the treatment of COVID-192213-422010.1016/j.imr.2021.100781https://doaj.org/article/b78c2d592a614450873b1aef202579362021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2213422021000688https://doaj.org/toc/2213-4220Background: The outbreak of COVID-19 has swiftly spread across China and all over the world, resulting in severe contagious pneumonia. However, no specific anti-COVID-19 drugs or methods are available for the treatment of this acute and fatal disease. In recent years, as the efficacy and safety of traditional Chinese medicine (TCM) have been universally acknowledged, it has been brought to a crucial status domestically and overseas for the treatment of COVID-19. Methods: We searched relevant literature, electronic databases, and official statements, diagnoses and protocols to retrieve studies and applications related to traditional Chinese medicine for COVID-19 in terms of regulations and policies, clinical evidence, preclinical rationale and big data analysis and then summarized the discovery and development of potential drugs and their targets. Results: Clinicians, researchers, governments, the public, colleges, institutes and companies collected and classified associated policies, regulations and actual contributions, searched clinical trials and preclinical experimental outcomes from databases, studied potential TCM drugs with possible mechanisms, retrieved numerous big data analysis method and gathered pooled results of compounds along with their effective targets to make traditional Chinese medicine vital to cover all stages of patients in the treatment and control of COVID-19. Conclusion: Traditional Chinese medicine provides new evidence to support the clinical value of TCM for COVID-19.Tieying DaiLeyin ZhangXinyang DaiXinran ZhangBeibei LuYuxi ZhengDeyi ShenYici YanCongqi JiJieru YuLeitao SunElsevierarticleTraditional Chinese medicine (TCM)COVID-19Multimode participationTreatmentMiscellaneous systems and treatmentsRZ409.7-999ENIntegrative Medicine Research, Vol 10, Iss , Pp 100781- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Traditional Chinese medicine (TCM) COVID-19 Multimode participation Treatment Miscellaneous systems and treatments RZ409.7-999
spellingShingle	Traditional Chinese medicine (TCM) COVID-19 Multimode participation Treatment Miscellaneous systems and treatments RZ409.7-999 Tieying Dai Leyin Zhang Xinyang Dai Xinran Zhang Beibei Lu Yuxi Zheng Deyi Shen Yici Yan Congqi Ji Jieru Yu Leitao Sun Multimode participation of traditional Chinese medicine in the treatment of COVID-19
description	Background: The outbreak of COVID-19 has swiftly spread across China and all over the world, resulting in severe contagious pneumonia. However, no specific anti-COVID-19 drugs or methods are available for the treatment of this acute and fatal disease. In recent years, as the efficacy and safety of traditional Chinese medicine (TCM) have been universally acknowledged, it has been brought to a crucial status domestically and overseas for the treatment of COVID-19. Methods: We searched relevant literature, electronic databases, and official statements, diagnoses and protocols to retrieve studies and applications related to traditional Chinese medicine for COVID-19 in terms of regulations and policies, clinical evidence, preclinical rationale and big data analysis and then summarized the discovery and development of potential drugs and their targets. Results: Clinicians, researchers, governments, the public, colleges, institutes and companies collected and classified associated policies, regulations and actual contributions, searched clinical trials and preclinical experimental outcomes from databases, studied potential TCM drugs with possible mechanisms, retrieved numerous big data analysis method and gathered pooled results of compounds along with their effective targets to make traditional Chinese medicine vital to cover all stages of patients in the treatment and control of COVID-19. Conclusion: Traditional Chinese medicine provides new evidence to support the clinical value of TCM for COVID-19.
format	article
author	Tieying Dai Leyin Zhang Xinyang Dai Xinran Zhang Beibei Lu Yuxi Zheng Deyi Shen Yici Yan Congqi Ji Jieru Yu Leitao Sun
author_facet	Tieying Dai Leyin Zhang Xinyang Dai Xinran Zhang Beibei Lu Yuxi Zheng Deyi Shen Yici Yan Congqi Ji Jieru Yu Leitao Sun
author_sort	Tieying Dai
title	Multimode participation of traditional Chinese medicine in the treatment of COVID-19
title_short	Multimode participation of traditional Chinese medicine in the treatment of COVID-19
title_full	Multimode participation of traditional Chinese medicine in the treatment of COVID-19
title_fullStr	Multimode participation of traditional Chinese medicine in the treatment of COVID-19
title_full_unstemmed	Multimode participation of traditional Chinese medicine in the treatment of COVID-19
title_sort	multimode participation of traditional chinese medicine in the treatment of covid-19
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/b78c2d592a614450873b1aef20257936
work_keys_str_mv	AT tieyingdai multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT leyinzhang multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT xinyangdai multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT xinranzhang multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT beibeilu multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT yuxizheng multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT deyishen multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT yiciyan multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT congqiji multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT jieruyu multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19 AT leitaosun multimodeparticipationoftraditionalchinesemedicineinthetreatmentofcovid19
_version_	1718372990298619904

Multimode participation of traditional Chinese medicine in the treatment of COVID-19

Ejemplares similares